tiprankstipranks
Trending News
More News >
Glow LifeTech (TSE:GLOW)
:GLOW
Advertisement

Glow LifeTech (GLOW) AI Stock Analysis

Compare
4 Followers

Top Page

TSE:GLOW

Glow LifeTech

(GLOW)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 4o)
Rating:42Neutral
Price Target:
C$0.00
▼(-100.00% Downside)
The overall stock score is primarily impacted by the company's financial performance, which is hindered by significant net losses and cash flow challenges. Technical analysis provides a neutral outlook with some short-term bullish signals, but valuation remains unattractive due to negative earnings. The lack of earnings call insights and corporate events means these factors do not influence the score.

Glow LifeTech (GLOW) vs. iShares MSCI Canada ETF (EWC)

Glow LifeTech Business Overview & Revenue Model

Company DescriptionGlow LifeTech (GLOW) is a cutting-edge biotechnology firm specializing in the development of innovative health and wellness products that harness the power of natural ingredients and advanced technology. The company operates primarily in the health and wellness sector, focusing on creating supplements, skincare solutions, and wellness devices aimed at enhancing overall well-being. With a commitment to sustainability and efficacy, GLOW leverages scientific research to formulate products that meet the evolving needs of health-conscious consumers.
How the Company Makes MoneyGlow LifeTech generates revenue through multiple streams, primarily from the sale of its health supplements and skincare products through both online and offline retail channels. The company operates a direct-to-consumer e-commerce platform, which allows it to capture higher margins by selling directly to customers. Additionally, GLOW has established partnerships with various health and wellness retailers, providing its products in physical stores and expanding its market reach. The company also engages in subscription-based models for certain product lines, ensuring consistent revenue flow. Furthermore, GLOW invests in research and development to innovate new products, which can lead to increased sales and market share, thereby enhancing its financial performance.

Glow LifeTech Financial Statement Overview

Summary
Glow LifeTech is experiencing strong revenue growth, but profitability remains elusive with significant net losses. The balance sheet shows a low debt burden, but the company struggles with negative equity returns. Cash flow challenges persist, indicating a need for improved operational efficiency and cost management to achieve sustainable profitability.
Income Statement
35
Negative
Glow LifeTech has shown significant revenue growth of 51.4% in the latest year, which is a positive indicator. However, the company is still operating at a loss with a negative net profit margin of -317.75% and negative EBIT and EBITDA margins. The high gross profit margin of 70.68% suggests potential for profitability if operational efficiencies improve.
Balance Sheet
40
Negative
The company's debt-to-equity ratio is relatively low at 0.16, indicating manageable debt levels. However, the negative return on equity of -103.37% highlights significant losses relative to shareholder equity. The equity ratio of 69.06% suggests a strong equity base compared to total assets, but overall financial health is weakened by persistent losses.
Cash Flow
30
Negative
Glow LifeTech's cash flow situation remains challenging with negative operating cash flow and free cash flow. The free cash flow to net income ratio is slightly positive at 1.01, indicating that free cash flow covers net income losses. However, the negative operating cash flow to net income ratio reflects ongoing cash burn issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.45M836.19K43.93K0.000.000.00
Gross Profit696.10K591.00K-759.18K-263.26K-43.39K0.00
EBITDA-1.28M-1.24M-1.31M-1.92M-4.59M-153.00K
Net Income-2.62M-2.66M-1.59M-2.24M-11.31M-153.00K
Balance Sheet
Total Assets3.69M3.72M1.91M2.31M3.76M2.60K
Cash, Cash Equivalents and Short-Term Investments1.06M1.29M34.0075.19K746.02K1.80K
Total Debt486.27K404.08K171.75K147.36K39.93K6.40K
Total Liabilities1.42M1.15M2.35M1.14M328.03K315.57K
Stockholders Equity2.26M2.57M-433.12K1.16M3.44M-312.97K
Cash Flow
Free Cash Flow-1.10M-1.36M-490.86K-1.36M-3.62M-18.65K
Operating Cash Flow-1.06M-1.35M-417.26K-1.30M-3.18M-18.65K
Investing Cash Flow-31.79K16.70K-60.91K18.31K-541.41K-1.36K
Financing Cash Flow1.79M2.62M445.01K491.44K4.59M2.93K

Glow LifeTech Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.06
Price Trends
50DMA
0.05
Positive
100DMA
0.05
Positive
200DMA
0.06
Positive
Market Momentum
MACD
<0.01
Negative
RSI
54.29
Neutral
STOCH
133.33
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GLOW, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and above the 200-day MA of 0.06, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 54.29 is Neutral, neither overbought nor oversold. The STOCH value of 133.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:GLOW.

Glow LifeTech Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
C$16.23M-3.93%-575.24%
42
Neutral
C$9.39M-2.72-250.28%327.55%21.37%
42
Neutral
C$4.99M-2.19
29
Underperform
$7.43M-1.1525.09%
21
Underperform
$10.63M-11.6785.61%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:GLOW
Glow LifeTech
0.06
0.00
0.00%
TSE:IOT
Innovotech
0.22
0.07
46.67%
TSE:KNE
Kane Biotech
0.03
-0.08
-72.73%
TSE:BLAB
Britannia Life Sciences Inc
0.10
0.05
100.00%
TSE:BETR
BetterLife Pharma
0.06
-0.07
-52.00%
TSE:BIOV
BioVaxys Technology
0.24
-0.46
-65.71%

Glow LifeTech Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Glow Lifetech Enhances Financial Structure with Warrant Exercise and Debt Settlement
Positive
Oct 28, 2025

Glow Lifetech Corp. has strengthened its financial position by exercising over 9 million warrants, generating $452,500, and allowing over 11 million warrants to expire, reducing potential dilution and simplifying its capital structure. These actions, along with settling $50,000 in debt through share issuance, enhance Glow’s financial flexibility and support its strategic growth initiatives.

Business Operations and StrategyPrivate Placements and FinancingProduct-Related Announcements
Glow Lifetech Expands Nationally with Key Retail Partnerships and Strengthens Financial Position
Positive
Oct 20, 2025

Glow Lifetech Corp. has announced significant commercial growth with the expansion of its MOD™ products into over 60 One Plant cannabis stores across Ontario and Saskatchewan. This strategic partnership with One Plant, a leading Canadian cannabis retailer, enhances Glow’s national distribution and positions the company for future growth opportunities. Additionally, Glow has successfully completed its first shipment to Saskatchewan, marking its entry into Western Canada with 10 product listings across its MOD™ and .decimal™ brands. To support its growth initiatives, Glow is also strengthening its financial position by settling outstanding debt through the issuance of common shares, preserving cash for working capital.

Business Operations and Strategy
Glow Lifetech Expands into Saskatchewan, Strengthening National Growth Strategy
Positive
Sep 16, 2025

Glow Lifetech Corp. has announced the expansion of its MOD™ and .decimal™ brands into the Saskatchewan cannabis retail market, marking a significant step in its national growth strategy. This expansion into Western Canada is part of Glow’s broader strategy to scale its operations across the country by leveraging its success in Ontario. The company aims to deepen its market penetration in Ontario while strategically entering new provinces, reflecting its disciplined growth strategy and positioning it for sustainable growth and long-term value creation.

Business Operations and StrategyFinancial DisclosuresProduct-Related Announcements
Glow Lifetech Achieves 196% Revenue Growth in Q2 2025, Strengthens Market Position
Positive
Aug 28, 2025

Glow Lifetech Corp. reported a significant 196% year-over-year revenue growth in Q2 2025, alongside improved cash flow and financial strength. The company has expanded its production capacity and market penetration, particularly in Ontario’s cannabis retail sector, and has launched new products under its MOD™ brand. These developments position Glow for scalable growth and enhanced profitability in the latter half of 2025, as it continues to build market leadership and sustainable value.

Business Operations and StrategyProduct-Related Announcements
Glow Lifetech Expands MOD™ Brand into FIKA Stores Across Ontario
Positive
Aug 20, 2025

Glow Lifetech Corp. has announced the significant expansion of its MOD™ brand into over 100 FIKA Company stores across Ontario, one of Canada’s largest cannabis retailers. This move marks a crucial step in Glow’s commercial growth strategy, enhancing its retail presence and setting the stage for broader national distribution opportunities. The company is implementing a targeted retail activation program to support this launch, aiming to drive awareness and sales performance, thereby reinforcing its market position and growth momentum.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 09, 2025